Latest Breaking News On - Jinsheng ren - Page 1 : comparemela.com

Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart

On November 21, 2023, Simcere Pharmaceutical Group Limited ("Simcere") entered into an exclusive license and collaboration agreement (the "Agreement") with Connect Biopharma HongKong Limited ("Connect") in relation to Rademikibart, an innovative IL-4Rα monoclonal antibody.

Jinsheng renDuplizumab dupixentSimcere pharmaceutical groupDrug administrationGreater chinaPharmaceutical groupConnect biopharma hongkong limitedInflammatory diseasesClinical trialGreater chinaSimcere pharmaceutical group limitedSynergistic effectCommercialization effortsMonoclonal antibody

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Zheng weiHong kongJinsheng renTim mccarthySimcere pharmaceutical groupCompany annual report on formBiopharma holdings limited nasdaqOncology drug developmentCompany greater chinaSuzhou connect biopharma co ltdSimcere pharmaceutical group ltdKey laboratory of neurologyExchange commissionSimcere pharmaceutical co ltdBiopharma hong kongBiopharma holdings

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zheng weiHong kongJinsheng renBiopharma hong kongSimcere pharmaceutical co ltdBiopharma holdings limited nasdaqSimcere pharmaceutical group ltdSuzhou connect biopharma co ltdConnect biopharma holdings limitedConnect biopharma hong kong limitedSimcere pharmaceutical groupConnect biopharmaGreater china

Idorsia s Daridorexant: Company Enters Into Licensing Agreement

Idorsia entered into a licensing agreement in China for Idorsia's daridorexant, an orexin antagonist medication used for insomnia.

Hong kongJinsheng renJean paul clozelSimcere pharmaceuticalsNational medical products administrationMainland chinaChief executive officer

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

/PRNewswire/ Simcere Pharmaceutical Group Ltd (2096.HK, "Simcere"), an innovation and R&D-driven pharmaceutical company,and Idorsia Ltd (SIX: IDIA,.

United statesHong kongUnited kingdomGreat britainJinsheng renJean paul clozelJ clin pharmacolIdorsia ltdAmerican psychiatric associationSimcere pharmaceutical groupEuropean commission decision reliance procedureEuropean commissionPrnewswire simcere pharmaceutical group ltdDrug administrationSwiss exchangeRegulatory agency